31 October 2024
Assura plc
Notice of Interim Results & Retail Investor Presentation
Assura plc ("the Company"), the UK's leading diversified healthcare REIT will announce results for the six months ended 30 September 2024 on Thursday 14 November 2024.
A presentation for analysts and investors, immediately followed by a Q&A with members of the senior management team, can be viewed at 10.00 am GMT at the following link:
https://brrmedia.news/AGR_HY_24
Additional Investor Presentation for Retail Investors via Investor Meet Company
Assura plc is also pleased to announce that Jonathan Murphy and Jayne Cottam will provide a live presentation relating to the Interim Results via Investor Meet Company on 15 Nov 2024, 1.00pm GMT.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 14 Nov 2024, 9.00am GMT, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Assura via:
https://www.investormeetcompany.com/assura-plc/register-investor
Investors who already follow Assura on the Investor Meet Company platform will automatically be invited.
- Ends -
For more information, please contact:
| Assura plc | Tel: 0161 515 2043 |
| FGS Global Gordon Simpson | Tel: 0207 251 3801 |
Notes to Editors
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.
A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.
At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.